Herpes Virus: nanotechnology against cancer

Categoria: Archive Cancer Food and Drug Administration (FDA) Genetics (DNA) Intracorporeal devices Nanotechnology Virus
Tag: #breast cancer #Cancer #cancer cells #herpes #liver tumor #metastasis #NIH extension #test

Excluding skin cancers, breast cancer is, in one out of three cases, the type of cancer diagnosed in female patients. Our immune system is designed to fight cancer . T-cells in the human body belong to a group of white blood cells and play a central role in immunity. However, cancer cells cause T-cells to essentially fall asleep. The tumor sends out signals to inhibit the T-cells. Our herpes virus, on the other hand, is designed to awaken cells and modulate the immune system so that cancer cells are recognized and destroyed. Furthermore, the herpes virus can selectively replicate in cancer cells, but does not affect healthy cells. The herpes virus replicates autonomously in its own cells. Skin sores emerge only when the herpes virus replicates and kills normal cells. Cold can cause cells to die. The herpes virus just designed by researchers at the Health Sciences Center in New Orleans was aimed only at replicating and destroying cancer cells, thus killing the tumor. Patients will have no way of contracting the herpes virus. The next step is to demonstrate that the virus can boost the immune system. In addition to destroying cancer cells, this herpes virus also has the potential to be used as a vaccine. So for preventive purposes. The herpes virus is oncolytic, meaning it kills the tumor, but we want to see now if it can be engineered to boost the immune system and prevent metastasis . A German company, MediGene, is conducting clinical trials of this application and is already in Phase 3 trials for liver cancer. It has had significant results and within 6 months the experimentation will be completed and the results of this research made public. The virus was engineered to better spread among cancer cells as well. The virus causes all of the cancer cells to fuse together so that it can then destroy the cells more efficiently. The virus can be used as a vector to express other genes. More genes can be inserted to improve its ability to attack the tumor. History teaches us that cancer cannot be treated using drugs alone but we must look to new and innovative gene therapies if we want to move forward. And this seems to me to be an interesting point to make a significant breakthrough in gene therapy and molecular pharmacology. This experimentation now tending towards the end, is now leading to the preparation of these viruses under strict control of the Food & Drug Administration under the name of "Good Manufacturing Practices" or GMP. During phase 1 human viruses are obtained, for the first toxicological evaluation. Phase 2 trials are useful for expanding testing to a small group of patients, and Phase 3 trials use 100 to 200 patients. It will take at least three years to get to phase 3 of human trials. A government grant was obtained from the National Institutes of Health (NIH) to fund these studies. [via Louisiana State University ]

Publicato: 2022-12-28Da: Bio Blog

Potrebbe interessarti

test commozione cerebrale

Test per la diagnosi rapida della commozione cerebrale

Un team di neurologi dell’Università  del Michigan hanno sviluppato un semplicissimo test per diagnosticare rapidamente lievi commozioni cerebrali negli atleti. L’idea originale del test è venuta allo studente Ian Richardson figlio del professore associato del dipartimento di Fisioterapia e Riabilitazione. Il funzionamento è semplice ma efficace: i ricercatori si sono accorti che anche dopo una… Continua a leggere Test per la diagnosi rapida della commozione cerebrale

2010-02-18Bio Blog

Tumore alla prostata, dalla diagnosi alla cura

Una ricerca pubblicata sulla rivista Neoplasia ha dimostrato l’esistenza di un nuovo marcatore del tumore alla prostata: il gene di fusione NDGR1-ERG. Lo studio, condotto presso il Weill Cornell Medical Center dal team di Mark Rubin, mette a disposizione un modo più accurato per diagnosticare questo tipo di cancro e un potenziale nuovo bersaglio per… Continua a leggere Tumore alla prostata, dalla diagnosi alla cura

2009-07-28Bio Blog

L’analisi delle urine per diagnosticare l’appendicite

Dagli USA arriva un pratico test delle urine per diagnosticare l’appendicite, cioè quell’infiammazione dell’appendice, molto comune soprattutto tra bambini ed adolescenti, che causa mal di pancia e fitte insopportabili. Un tempo la diagnosi era effettuata con l’ecografia. Così capitava che appena identificata la patologia il paziente finiva ”sotto i ferri”, anche se non sempre l’operazione… Continua a leggere L’analisi delle urine per diagnosticare l’appendicite

2009-07-03Bio Blog

Rivoluzionario test diagnostico prenatale per individuare le malattie cromosomiche

«Attualmente il test diagnostico prenatale sviluppato da Bouty, il GOLDchip (Gain Or Loss Detection Chip, ndr), può essere svolto solo in alcuni istituti privati altamente specializzati, ma nel giro di un paio di mesi entrerà  nel tariffario del Servizio sanitario nazionale ed ogni donna che lo necessiterà  potrà  usufruirne». Queste le previsioni di Salvatore De… Continua a leggere Rivoluzionario test diagnostico prenatale per individuare le malattie cromosomiche

2009-05-21Bio Blog